Vimarsana
Biggest News Aggregation in the World

Page 2 - Altavant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altavant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altavant Sciences Today - Breaking & Trending Today

Global Respiratory Disease Partnering Report and Directory 2022: Company A-Z, Stage of Development at Signing, Deal Type (Collaborative R&D, Co-promotion, Licensing) and Technology Type - Vimarsana News

Global Respiratory Disease Partnering Report and Directory 2022: Company A-Z, Stage of Development at Signing, Deal Type (Collaborative R&D, Co-promotion, Licensing) and Technology Type

/PRNewswire/ -- The "Global Respiratory Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering....

Enzyvant Stages NC HQ for Rare-Disease Battles | North Carolina Biotechnology Center - Vimarsana News

Enzyvant Stages NC HQ for Rare-Disease Battles | North Carolina Biotechnology Center

Enzyvant and Altavant, wholly owned subsidiaries of Sumitovant Biopharma, are forming a Triangle-based rare-disease biopha company.

Pulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsight - Vimarsana News

Pulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsight

DelveInsight’s pulmonary hypertension pipeline report depicts a robust space with 80+ active players working to develop...

Worldwide Genitourinary Partnering Industry 2022 Report - Featuring 3SBio, 4D Science, 180 Medical, A1M Pharma and Many More - Vimarsana News

Worldwide Genitourinary Partnering Industry 2022 Report - Featuring 3SBio, 4D Science, 180 Medical, A1M Pharma and Many More

/PRNewswire/ -- The "Global Genitourinary Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering....

The Lung Transplant Foundation to Host Externally-Led Patient-Focused Drug Development Meeting to Help Educate FDA on Living with Bronchiolitis Obliterans Syndrome (BOS) - Vimarsana News

The Lung Transplant Foundation to Host Externally-Led Patient-Focused Drug Development Meeting to Help Educate FDA on Living with Bronchiolitis Obliterans Syndrome (BOS)

/PRNewswire/ -- The Lung Transplant Foundation (LTF), a non-profit organization dedicated to creating a world where all lung transplant patients live long,...